Literature DB >> 25019652

Fluoxetine and WAY 100,635 dissociate increases in scototaxis and analgesia induced by conspecific alarm substance in zebrafish (Danio rerio Hamilton 1822).

Caio Maximino1, Monica Gomes Lima2, Carina Cardoso Costa3, Iêda Maria Louzada Guedes4, Anderson Manoel Herculano5.   

Abstract

Alarm reactions to a substance secreted by the damaged skin of conspecifics and closely-related species are increasingly being recognized as fear-like responses in fish. The neurochemical underpinnings of these effects are so far unknown; however, given the role of the serotonergic system on defensive behavior, it is possible that the alarm reaction is mediated by this monoamine. Exposure to conspecific alarm substance (CAS) increased anxiety-like behavior in the light/dark test in zebrafish and decreased nocifensive behavior. These effects were accompanied by increases in blood glucose, hemoglobin, epinephrine and norepinephrine levels, as well as extracellular levels of serotonin in the brain. Pretreatment with fluoxetine blocked the anxiogenic effects of CAS on the light/dark test as well as all physiological parameters and the increase in extracellular brain 5-HT, but not the reduction in nocifensive behavior. Conversely, pretreatment with the 5-HT1AR antagonist WAY 100635 blocked the effects on nocifensive behavior, but not the effects on anxiety-like behavior nor on physiological parameters. These results point to an important and complex role of the serotonergic system in the mediation of fear-potentiated behavior in the light/dark test and in fear-induced analgesia in zebrafish.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alarm substance; Fear; Nocifensive behavior; Scototaxis; Serotonin; Zebrafish

Mesh:

Substances:

Year:  2014        PMID: 25019652     DOI: 10.1016/j.pbb.2014.07.003

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  7 in total

1.  Concentration, population, and context-dependent effects of AM251 in zebrafish.

Authors:  Steven Tran; Diptendu Chatterjee; Amanda Facciol; Robert Gerlai
Journal:  Psychopharmacology (Berl)       Date:  2016-02-16       Impact factor: 4.530

2.  Developing highER-throughput zebrafish screens for in-vivo CNS drug discovery.

Authors:  Adam Michael Stewart; Robert Gerlai; Allan V Kalueff
Journal:  Front Behav Neurosci       Date:  2015-02-12       Impact factor: 3.558

3.  Acute Exposure to Fluoxetine Alters Aggressive Behavior of Zebrafish and Expression of Genes Involved in Serotonergic System Regulation.

Authors:  Antonia Theodoridi; Aleka Tsalafouta; Michail Pavlidis
Journal:  Front Neurosci       Date:  2017-04-25       Impact factor: 4.677

4.  Divergent effect of fluoxetine on the response to physical or chemical stressors in zebrafish.

Authors:  Murilo S Abreu; Ana Cristina V V Giacomini; Gessi Koakoski; Angelo L S Piato; Leonardo J G Barcellos
Journal:  PeerJ       Date:  2017-05-09       Impact factor: 2.984

5.  Habenula kisspeptin retrieves morphine impaired fear memory in zebrafish.

Authors:  Mageswary Sivalingam; Satoshi Ogawa; Ishwar S Parhar
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.379

6.  Anxiolytic-like effect of natural product 2-hydroxy-3,4,6-trimethoxyacetophenone isolated from Croton anisodontus in adult zebrafish via serotonergic neuromodulation involvement of the 5-HT system.

Authors:  Antonio Wlisses da Silva; Maria Kueirislene A Ferreira; Emanuela L Rebouças; Francisco Rogenio S Mendes; Atilano Lucas Dos S Moura; Jane Eire S A de Menezes; Márcia Machado Marinho; Emmanuel Silva Marinho; Hélcio S Santos; Alexandre M R Teixeira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-07-12       Impact factor: 3.000

Review 7.  Non-mammalian models in behavioral neuroscience: consequences for biological psychiatry.

Authors:  Caio Maximino; Rhayra Xavier do Carmo Silva; Suéllen de Nazaré Santos da Silva; Laís do Socorro Dos Santos Rodrigues; Hellen Barbosa; Tayana Silva de Carvalho; Luana Ketlen Dos Reis Leão; Monica Gomes Lima; Karen Renata Matos Oliveira; Anderson Manoel Herculano
Journal:  Front Behav Neurosci       Date:  2015-09-08       Impact factor: 3.558

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.